![](https://ngs-space1.sgp1.cdn.digitaloceanspaces.com/am/uploads/resources/am-article-default.jpg)
Others SciTech
Clinical trials of TB vaccine begin in India
- Clinical trials of TB vaccine begin in India Ahmedabad Mirror
- Bharat Biotech starts clinical trials of TB jab The Economic Times
- Bharat Biotech begins clinical trials of more effective TB vaccine in India The Times of India
- Clinical trials of Spanish tuberculosis vaccine MTBVAC begin in India The Hindu
- World Tuberculosis Day 2024: Vaccines in late-stage development hold promise in tackling disease burden, says GlobalData The Financial Express
=> Clinical trials
of TB vaccine begin in India
Clinical trials of TB vaccine begin in India =>
)
Clinical trials of TB vaccine begin in India
#Hyderabad:
The clinical trials of MTBVAC, the Spanish tuberculosis vaccine, began among adults in India.
The trials of the first live attenuated vaccine of Mycobacterium tuberculosis isolated from a human are being carried out by Bharat Biotech in close collaboration with Biofabri, a Spanish biopharmaceutical company.
Trials to evaluate the safety and immunogenicity of MTBVAC have started with a pivotal safety, immunogenicity and efficacy trial planned to start in 2025, the companies said in a joint statement on Sunday “After more than three decades of research, it is a giant step to test in adults and adolescents in the country where 28% of world’s TB cases accumulate,” said Esteban Rodriguez, CEO of Biofabri. The only vaccine in use today, BCG, is an attenuated variant of the bovine TB pathogen. It is more than 100 years old and has a very limited effect on pulmonary tuberculosis, which is responsible for the transmission of the disease. The companies hope the new vaccine will be a milestone in global vaccinology and called it an example of public-private, national and international collaboration.PTI